Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients

被引:0
作者
Gregory Lucien Bellot
Wei Han Tan
Ling Lee Tay
Dean Koh
Xueying Wang
机构
[1] National University of Singapore,Department of Biochemistry, Centre for Life Science (CeLS), Yong Loo Lin School of Medicine
[2] National University of Singapore,Cancer Science Institute of Singapore (CSI)
[3] National University of Singapore,Department of Surgery
来源
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词
Colorectal cancer; Primary cultures; Drug assays; Microarray; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:463 / 482
页数:19
相关论文
共 282 条
  • [1] Alberts DS(1980)In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy Lancet 2 340-342
  • [2] Samon SE(2004)Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells Br J Cancer 91 1931-1946
  • [3] Chen HS(2005)Gene-expression profiling predicts recurrence in Dukes’ C colorectal cancer Gastroenterology 129 874-884
  • [4] Surwit EA(2011)Mycorrhizal symbiosis stimulates endoreduplication in angiosperms Plant Cell Environ 34 1577-1585
  • [5] Soehnlen B(2005)Colon cancer prognosis prediction by gene expression profiling Oncogene 24 6155-6164
  • [6] Young L(2005)Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients Dis Colon Rectum 48 2238-2248
  • [7] Arango D(2006)Stage II colon cancer prognosis prediction by tumor gene expression profiling J Clin Oncol 24 4685-4691
  • [8] Wilson A(2007)Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling Oncogene 26 2642-2648
  • [9] Shi Q(2009)SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Nat Genet 41 1238-1242
  • [10] Corner G(2005)Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell’Italia Meridionale (GOIM) prospective study Ann Oncol 16 iv50-iv55